Physician profile
Richard Mooney
NPI 1700981685
$4,419.78
in general payments reported to CMS, 2019-2025
25 companies · $890 in 2025
The $890 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $136 · 2021: $479 · 2022: $450 · 2023: $599 · 2024: $881 · 2025: $890.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,369.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,192.20 | 2021-2025 | Interstim |
| Stryker Corporation | $967.87 | 2019 | |
| Coloplast Corp | $915.04 | 2021-2025 | Altis, Restorelle |
| Intuitive Surgical, INC. | $249.17 | 2021 | |
| Caldera Medical, INC | $167.41 | 2022 | |
| Hologic Sales and Service, LLC | $138.95 | 2024 | Acessa Provu System, Aptima |
| Abbvie INC. | $131.66 | 2021-2023 | |
| Pfizer INC. | $124.66 | 2020-2022 | |
| Astellas Pharma US INC | $115.93 | 2022-2024 | Veozah |
| Boston Scientific Corporation | $52.50 | 2022-2025 | Advantage System, Axonics |
| Bluewind Medical | $48.30 | 2025 | Revi |
| Therapeuticsmd, INC. | $34.21 | 2020 | |
| Axonics, INC. | $31.71 | 2023 | Bulkamid |
| Medtronic USA, INC. | $30.46 | 2020 | |
| Urovant Sciences INC | $27.69 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $27.30 | 2022 | |
| Laborie Medical Technologies Corp. | $23.00 | 2025 | |
| Medline Industries LP | $21.57 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.03 | 2022 | |
| Applied Medical Resources Corporation | $18.54 | 2024 | |
| Aspira Women'S Health INC | $18.19 | 2022 | |
| Daiichi Sankyo INC. | $17.97 | 2022 | |
| Merck Sharp & Dohme LLC | $16.54 | 2019 | |
| Coopersurgical, INC. | $15.54 | 2020 | |
| Sumitomo Pharma America, INC. | $14.34 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Mooney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.